Lin Lin

3.5k citations
100 papers · 2.4k indexed · h-index 28
Topics
Cancer-related molecular mechanisms research (29 papers)MicroRNA in disease regulation (23 papers)Circular RNAs in diseases (15 papers)

In The Last Decade

Lin Lin

95 papers receiving 2.4k citations

Peers

Lin Lin
Comparison fields: 5 of 109
  • Molecular Biology 1.4k
  • Cancer Research 1.2k
  • Oncology 323
  • Physiology 286
  • Immunology 193
Replace Ferdinando Chiaradonna with:
Ferdinando Chiaradonna Italy
Zachary T. Schafer United States
Elaine D. MacKenzie United Kingdom
Taro Hitosugi United States
Lucia Magnelli Italy
Dimitrios Anastasiou United Kingdom
Torben Ørntoft Denmark
Kiranmai Gumireddy United States
Haifeng Zhang China
Lin Lin relative to Ferdinando Chiaradonna Italy Ferdinando Chiaradonna's profile →
Citations per field
00.5×2.8×
Ferdinando Chiaradonna · 1×
Citations per year

Countries citing papers authored by Lin Lin

Since Specialization
Citations

This map shows the geographic impact of Lin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Lin more than expected).

Fields of papers citing papers by Lin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Lin. The network helps show where Lin Lin may publish in the future.

Co-authorship network of co-authors of Lin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Lin. A scholar is included among the top collaborators of Lin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Lin. Lin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 6
4 2
5 1
6 2
7 16
8 2
9
Long non-coding RNA H19 and the underlying epigenetic function in response to DNA damage of lung cancer cells.
8
10 58
11 14
12 17
13 27
14 5
15 53
16 4
17 0
18 61
19 69
20 41

About Lin Lin

Lin Lin is a scholar working on Cancer Research, Molecular Biology and Physiology, having authored 100 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (29 papers), MicroRNA in disease regulation (23 papers) and Circular RNAs in diseases (15 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.4k citations) and Hematology (134 citations). Lin Lin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Mingdong Huang, Bruce Furie, Barbara C. Furie, Qing Huai, Mingdong Huang, Cai Yuan, Henrik Gårdsvoll, Michael Ploug, David G. Beer and Hongzhi Lu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026